SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate upcoming earnings, with community chatter focused on potential S&P 500 inclusion and the impact of future interest rate cuts. Bullish sentiment is high, with some expecting a significant price increase following earnings, while others are wary of a potential sell-off. The community is actively discussing potential earnings leaks and institutional buying patterns.

Pump.fun

$PUMP is gaining traction within the Solana meme coin ecosystem, particularly on Pump.fun, with the community rallying around a 'We're All Gonna Make It' ($WAGMI) mentality. Traders are closely watching for meme rotations and potential breakouts, emphasizing community support and long-term holding.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending due to a recent $1B convertible note offering, leading to community debate on whether it's a strategic move for data center expansion or a dilution risk.  Despite strong earnings and expansion plans, investors are wary, drawing comparisons to other crypto firms and questioning the timing of the offering. Discussions also involve the company's potential ERCOT approval for its Texas data center campus.

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZ is trending due to discussions around its stock repurchase program and the potential impact of Ethereum's price movements on the company's value. Community members are debating the company's strategy of selling ETH to buy back shares, with some seeing it as a smart move and others questioning its long-term viability. Broader market factors, including potential agreements between the U.S. and China, and the performance of other crypto-related stocks, are also influencing the conversation.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending due to its announcement of new AI accelerator chips, positioning the company to compete with Nvidia in the data center AI market.  The community is actively discussing whether Qualcomm's fundamentals support this rally and its potential to disrupt the AI space.  Traders are also weighing the impact of a recent analyst note and a major AI data center deal.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors debate its future ahead of upcoming earnings, with key concerns including potential dividend cuts, restructuring impacts, and the influence of Amazon. Community discussions revolve around whether UPS can maintain current levels or if a further decline is imminent. Sentiment is mixed, with some anticipating a significant move post-earnings while others point to the stock's long-term value and high dividend yield.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community rallies behind a bullish narrative, particularly around potential ETFs and the broader ecosystem's growth. Community members are laser-focused on 'WAGMI' (We're All Gonna Make It) and touting Solana's potential for new all-time highs. There's also discussion around various Solana-based meme coins and staking opportunities.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group (UNH) is trending as investors discuss upcoming earnings and potential market reactions. Community members are actively debating whether UNH will beat expectations, with some expressing nervousness about holding large positions through the release, while others analyze options strategies to capitalize on potential volatility. Broader discussions include the health sector's overall outlook and the impact of external factors like interest rate decisions.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is trending amid discussions about earnings and revenue, with community members pointing to the stock's valuation and margin performance. Despite positive momentum in DDR5 memory products and AI solutions, some traders express concerns about earnings quality. The stock's high valuation relative to earnings has sparked debate as it relates to the AI and memory technology sectors.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLA is trending due to a significant stock drop following a paused trial of its gene therapy nex-z after a patient experienced liver issues, sparking discussions around the severity and implications for the company's pipeline. The community is debating whether this is an overreaction and a buying opportunity, or a sign of deeper problems with the therapy, while analysts are adjusting price targets but largely maintaining buy ratings. Some traders anticipate a potential short squeeze given the high short interest and the company's cash reserves.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Core Scientific, Inc. (CORZ) Reports Q3 Loss, Misses Revenue Estimates

Core Scientific, Inc. (CORZ) delivered earnings and revenue surprises of +45.88% and -24.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Core Scientific Announces Fiscal Third Quarter 2025 Results

Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced financial results for the fiscal third quarter...

Tesla's Record Sales Mask Profit Slide  Open Interest 10/23/2025

Get a jump start on the US trading day with Matt Miller and Dani Burger on 'Bloomberg Open Interest.' Tesla's profit slump sets a cautious tone ahead of results from Ford and Intel. Oil surges as...

<ul class="summary-bullets"><li>VanEck now owns 2.2 million shares of Core Scientific and will vote against its merger with CoreWeave.</li><li>The investment management firm cited AI infrastructure potential as the primary reason for opposing the merger,</li><li>The firm added Core Scientific to its “laggards” list and sold its CoreWeave shares in the VanEck Onchain Economy ETF.</li></ul>Matthew Sigel, head of digital assets research at VanEck, said Thursday that the firm now owns 2.2 million shares of Core Scientific (CORZ) and will vote against the company’s planned merger with CoreWeave (CRWV).In morning trade,&nbsp;<a href="http://stocktwits.com/symbol/CORZ">Core Scientific’s stock</a> shares fell 2.7%, though retail sentiment on Stocktwits remained in ‘bullish’ territory, with chatter around the stock at ‘high’ levels over the past 24 hours.&nbsp;<a href="http://stocktwits.com/symbol/CRWV">CoreWeave’s stock</a> inched 0.6% higher, but retail sentiment shifted further into ‘bearish’ territory.<h2 class="st-heading-2">VanEck Cites AI Potential In Voting Against Merger</h2>According&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/matthew_sigel/status/1981364788190961850">to</a> Sigel, VanEck’s decision to oppose the deal between CoreWeave and Core Scientific stems from its belief in Core Scientific’s AI potential. With its stake, VanEck is now the 28th-largest shareholder in CORZ. The firm has also added Core Scientific to its “laggards” list, signaling a strategic focus on potential long-term upside rather than immediate merger outcomes.<blockquote>“We believe Core Scientific can help lead the next phase of AI infrastructure.”&nbsp;– Matthew Sigel, Head of Digital Assets Research, VanEck</blockquote>In a separate&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/matthew_sigel/status/1981368967894880754">post</a> on X, Sigel noted that VanEck sold the CoreWeave shares previously held in its VanEck Onchain Economy ETF (NODE).&nbsp;<a href="http://stocktwits.com/symbol/NODE">NODE</a> rose 1.3% in premarket trading, with retail sentiment around the ETF on Stocktwits largely in ‘neutral’ territory over the past day.<figure class="image"><a class="st-link-external" href="https://x.com/matthew_sigel/status/1981368967894880754" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:917/657;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_23_111605_png_9831e41748.webp" alt="Screenshot 2025-10-23 111605.png" width="917" height="657"></a><figcaption>Source: @matthew_sigel/X</figcaption></figure><h2 class="st-heading-2">Other Major Investors Also Voice Opposition</h2>In a CNBC&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/10/21/coreweave-ceo-on-core-scientific-deal-as-shareholder-opposition-rises.html">interview</a> earlier this week, CoreWeave CEO Michael Intrator described Core Scientific as a “nice to have” rather than a necessity, adding that the company would not increase its offer.However, VanEck is just the latest of investors to voice their chagrin. Proxy advisory firms ISS and Glass Lewis have also urged Core Scientific shareholders to vote against the merger, citing unfavorable terms. In a statement, Glass Lewis&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/second-leading-independent-proxy-advisory-firm-glass-lewis-joins-iss-in-recommending-core-scientific-shareholders-vote-against-proposed-sale-to-coreweave-on-gold-proxy-card-302590537.html">said</a>, “The market’s prolonged discount of the deal’s implied value to Core Scientific’s share price—combined with the absence of any mechanisms to mitigate downside risk—indicates that the proposed exchange does not adequately compensate Core Scientific shareholders for the risks inherent in the CoreWeave consideration.”CoreWeave&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.coreweave.com/news/news-details/2025/CoreWeave-Comments-on-Proxy-Advisor-Recommendations-Regarding-Proposed-Acquisition-of-Core-Scientific/default.aspx">responded</a> to ISS and Glass Lewis, stating that it disagreed with the advisory firms’ findings. “While neither ISS nor Glass Lewis questions the strategic merit of the transaction, both base their recommendations largely on the current Core Scientific stock price and overlook the risks of a standalone Core Scientific,” the company said.Two Seas Capital, one of Core Scientific’s largest shareholders, also opposes the transaction.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-on-track-to-hit-110-00-after-china-says-trade-talks-with-us-set-for-friday/cLG4W8vR3Ap">Bitcoin On Track To Hit $110,00 After China Says Trade Talks With US Set For Friday</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the logo of 'Core Scientific' is seen on a mobile phone screen in front of the 'CoreWeave' logos displayed on a computer in Ankara, Turkiye on July 17, 2025. (Photo by Mustafa Hatipoglu/Anadolu via Getty Images)

VanEck Opposes Core Scientific Merger With CoreWeave Citing AI Potential

The investment management firm cited AI infrastructure potential as the primary reason for opposing the merger,

Equity

<ul class="summary-bullets"><li>Core Scientific derives a bulk of its total revenue from digital asset self-mining and hosted mining.</li><li>Core Scientific shareholders are scheduled to vote on the deal to be bought by CoreWeave in a special meeting to be held on Oct. 30.</li><li>CEO Michael Intrator reportedly clarified in an interview this week that CoreWeave would not sweeten its offer.</li></ul>Core Scientific (CORZ) stock is on track to rebound from Wednesday’s steep sell-off, with retail sentiment remaining upbeat. Following Wednesday’s 7.4%&nbsp;plunge,&nbsp;<a href="https://stocktwits.com/symbol/CORZ">CORZ stock</a>&nbsp;is headed for its worst week since early August.Dover, Delaware-based Core Scientific, a data center infrastructure and crypto mining company, has agreed to be taken over by Nvidia-backed CoreWeave (CRWV) in an all-stock transaction. Core Scientific shareholders would receive 0.1235 newly-issued Class A common stock for every CORZ stock they hold, translating to a total deal value of about $9 billion compared to Core Scientific’s current market capitalization of $5.471 billion.Buoyed by artificial intelligence (AI)-related demand for infrastructure and the CoreWeave deal, the stock has been on a broader uptrend since the post-tariff lows seen in early April. The stock had hit an all-time high of $20.36 (intraday) on Oct. 16 but has since retreated from the peak.<h2 class="st-heading-2">What’s Ailing CORZ Stock&nbsp;</h2>The recent weakness in Core Scientific stock may be partly attributed to the crypto market's weakness amid an uncertain geopolitical backdrop. <a href="https://stocktwits.com/coins/bitcoin">Bitcoin</a> has lost about 14% from its Oct. 6 peak of $126,198.07, indicating it is in correction territory.Core Scientific derives a bulk of its total revenue from digital asset self-mining and hosted mining. The second-quarter results released in early August showed that roughly 87% of the total revenue of $78.6 million was derived from these two segments. Colocation revenue related to high-performance computing hosting contributed only $10.6.Additionally, proxy advisory firms ISS and Glass Lewis have opposed the CoreWeave deal, urging Core Scientific shareholders to vote against the latter’s sale to the former.In a statement, Glass Lewis said, “The market's prolonged discount of the deal's implied value to Core Scientific's share price—combined with the absence of any mechanisms to mitigate downside risk—indicates that the proposed exchange does not adequately compensate Core Scientific shareholders for the risks inherent in the CoreWeave consideration.”&nbsp; Two Seas Capital, one of the largest Core Scientific shareholders, has also opposed the proposed transaction.Responding to the development, CoreWeave said in a statement released late Wednesday that it disagreed with the proxy firms’ rejection call. “While neither ISS nor Glass Lewis questions the strategic merit of the transaction, both base their recommendations largely on the current Core Scientific stock price and overlook the risks of a standalone Core Scientific,” it said.In a CNBC interview CEO, CoreWeave CEO Michael Intrator&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/10/21/coreweave-ceo-on-core-scientific-deal-as-shareholder-opposition-rises.html">said</a> earlier this week that Core Scientific would be a “nice to have” rather than a necessity, adding that CoreWeave would not sweeten its offer.<h2 class="st-heading-2">What Retail’s Feeling About Core Scientific Stock</h2>On Stocktwits, retail sentiment toward Core Scientific stock remained ‘bullish’ as of early Thursday, although down from the ‘extremely bullish’ sentiment seen from a week ago. The message volume on the CORZ stream remained ‘high.’A user expects Two Seas to call a special shareholder meeting if the merger proposal is rejected, to remove the full slate of directors and name a new CEO.<stembedurl>https://stocktwits.com/Rayyleee/message/633370800</stembedurl>Another user, however, said there is no future for Core Scientific if the deal does not go through.<stembedurl>https://stocktwits.com/Cloud_Data/message/633352356</stembedurl>Core Scientific shareholders are scheduled to vote on the deal in a special meeting to be held on Oct. 30. The original timeline for the completion of the agreement is the fourth quarter.In overnight trading, Core Scientific stock rose 1.12%, according to Yahoo Finance. The stock has gained about 27% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-administration-reportedly-mulls-quantum-investments/cLG4PlHR3q6">IONQ, QBTS, RGTI: Retail Traders Gear Up For ‘Explosive’ Moves As Trump Administration Reportedly Mulls Quantum Investments</a>

In this photo illustration, the Core Scientific Inc. logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Core Scientific Stock Heads For Worst Week In Nearly 3 Months Amid Crypto Selloff, CoreWeave Deal Uncertainty — But Retail Stays Upbeat

Core Scientific shareholders are scheduled to vote on the deal to be bought by CoreWeave in a special meeting to be held on Oct. 30.

LendingClub (LC) Q3 Earnings and Revenues Top Estimates

LendingClub (LC) delivered earnings and revenue surprises of +23.33% and +3.70%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

CoreWeave Comments on Proxy Advisor Recommendations Regarding Proposed Acquisition of Core Scientific

CoreWeave Inc. (NASDAQ: CRWV), The Essential Cloud for AI, today commented on the reports published by Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co. (Glass Lewis) regarding...

Second Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS In Recommending Core Scientific Shareholders Vote "AGAINST" Proposed Sale to CoreWeave on GOLD Proxy Card

Second Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS In Recommending Core Scientific Shareholders Vote 'AGAINST' Proposed Sale to CoreWeave on GOLD Proxy Card Second Leading...

GM Soars Most in Five Years  Bloomberg Open Interest 10/21/25

Get a jump start on the US trading day with Matt Miller and Dani Burger on 'Bloomberg Open Interest.' Earnings season kicks into high gear with Corporate America painting a surprisingly upbeat...

Leading Proxy Advisory Firm Institutional Shareholder Services Recommends Core Scientific Shareholders Vote "AGAINST" Sale to CoreWeave on GOLD Proxy Card

Leading Proxy Advisory Firm Institutional Shareholder Services Recommends Core Scientific Shareholders Vote 'AGAINST' Sale to CoreWeave on GOLD Proxy Card Leading Proxy Advisory Firm Institutional...

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Will Alphabet ($GOOGL) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Alphabet Inc Class A

) beat quarterly earnings? 
 
*Powered by Polymarket

CORZ
Core Scientific Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CORZ News

CORZCore Scientific Inc